United States Oral Solid Dosage Contract Manufacturing Market to Grow with a CAGR of 5.72% through 2029
Rising demand for generic drugs is expected to drive the
United States Oral Solid Dosage Contract Manufacturing Market in the forecast
period 2025-2029.
According
to TechSci Research report, “Oral Solid Dosage Contract
Manufacturing Market – United States Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2019-2029F”, the
United States Oral Solid Dosage Contract Manufacturing Market stood at USD 8.46
billion in 2023 and is anticipated to grow with a CAGR of 5.72% in the forecast
period, 2025-2029. The Oral Solid Dosage Contract Manufacturing sector is
integral to the pharmaceutical industry, providing strategic advantages through
outsourcing tablet and capsule production. Escalating demand for generic drugs
in the United States drives this market, offering cost-effective alternatives
and broadening healthcare access. Contract manufacturing organizations (CMOs)
efficiently produce generics, leveraging expertise and scale. Amidst a
pharmaceutical industry focus on research and development (R&D), companies
outsource existing drug manufacturing to CMOs, enabling resource allocation to
innovation and faster market entry. Modern drug complexities prompt
pharmaceutical-CMO partnerships, with CMOs handling intricate processes like
formulation, testing, and regulatory compliance. CMOs specialize in navigating
stringent U.S. Food and Drug Administration (FDA) standards, ensuring drug
quality and safety, making them vital allies for pharmaceutical companies.
Browse over XX market data Figures spread through XX
Pages and an in-depth TOC on "United
States Oral Solid Dosage Contract Manufacturing Market”
The
United States Oral Solid Dosage Contract Manufacturing Market is segmented into
mechanism, product type, end user, regional distribution, and company.
Based on end user, the large size companies
segment emerged as the dominant player in the United States market for United
States Oral Solid Dosage Contract Manufacturing Market in 2023. This is attributed
due to their extensive resources, established infrastructure, and proven track
record in handling complex manufacturing processes. These companies possess the
financial capability to invest in state-of-the-art facilities, cutting-edge
technology, and skilled workforce, ensuring efficient production and adherence
to strict regulatory standards. Additionally, their established reputation and
robust networks enable them to attract high-profile pharmaceutical clients,
consolidating their position as leaders in the market and further reinforcing
their dominance.
Based on product type, Capsules are
the fastest-growing segment among Tablets, Capsules, Powders, Granules, and
Others due to several factors. Capsules offer advantages such as easy
swallowing, customizable formulations, and faster dissolution rates, leading to
quicker onset of action. Moreover, they are preferred by patients who have
difficulty swallowing tablets. Additionally, advancements in capsule
technology, such as enteric coatings and specialized delivery systems, have
expanded their applications in targeted drug delivery and controlled-release
formulations. These factors, coupled with the increasing demand for
patient-centric dosage forms, drive the rapid growth of capsules in the
pharmaceutical market.
Based on region, Mid-West emerged
as the dominant player in the United States Oral Solid Dosage Contract
Manufacturing Market in 2023. This is due to its strategic advantages. It
boasts a central location, facilitating efficient distribution networks and
access to major transportation routes. The Midwest hosts renowned
pharmaceutical hubs like Chicago and Indianapolis, equipped with advanced
manufacturing facilities and skilled workforce. These factors, combined with favourable
business climates and supportive government policies, attract pharmaceutical
companies seeking reliable contract manufacturing partners. The concentration
of industry expertise and infrastructure positions the Midwest as a preferred
destination for oral solid dosage contract manufacturing, solidifying its
dominance in the market.
Major companies operating in United States Oral Solid
Dosage Contract Manufacturing Market are:
- Catalent,
Inc.
- Lonza
Group
- AbbVie
Inc.
- Aenova
Group
- Adare
Pharma Solutions
- Boehringer
Ingelheim International GmbH
- Jubilant
Pharmova Limited
- Patheon
Pharma Services
- Recipharm
AB
- Corden
Pharma International
Download Free Sample Report
Customers can also request for 10% free customization on
this report.
“The
United States Oral Solid Dosage Contract Manufacturing (NGS) market is poised
for significant growth in the coming years. This growth is anticipated due to
several key factors, including the increasing demand for generic drugs,
pharmaceutical companies' expanding focus on research and development, the
rising adoption of biopharmaceuticals, and the trend toward personalized
medicine. The market also benefits from the efficient and cost-effective
production of oral solid dosage forms like tablets and capsules, coupled with a
well-established pharmaceutical infrastructure and regulatory framework. The
heightened emphasis on innovative drug delivery mechanisms and sustainability
practices within the pharmaceutical industry is expected to further drive the
demand for contract manufacturing services” said Mr. Karan Chechi, Research
Director with TechSci Research, a research-based management consulting firm.
“United
States Oral Solid Dosage Contract Manufacturing Market Segmented By Product
Type (Tablets, Capsules, Powders, Granules, Others), By Mechanism (Immediate
Release, Delayed Release, Controlled Release), By End-user (Large Size
Companies, Medium & Small Size Companies, Others) Region and Competition,
Opportunity, and Forecast, 2019-2029F”, has evaluated the future growth potential of United
States Oral Solid Dosage Contract Manufacturing Market and provides statistics
& information on market size, structure and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in United States Oral Solid Dosage Contract Manufacturing Market.
Contact
Techsci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +13322586602
Email: [email protected]
Website: www.techsciresearch.com